September 19, 2022 by Jon Hennessey RIVUS_PHARMACEUTICALS_ANNOUNCES_POSITIVE_DATA_FROM_PHASE_2A_CLINICAL_TRIAL_OF_LEAD_CANDIDATE_HU6-1
September 19, 2022 by Jon Hennessey RIVUS_PHARMACEUTICALS_ANNOUNCES_POSITIVE_RESULTS_FROM_PHASE_1_TRIAL_OF_LEAD_CANDIDATE_HU6
September 19, 2022 by Jon Hennessey RIVUS_PHARMACEUTICALS_LAUNCHES_WITH_$35_MILLION_SERIES_A_FINANCING